Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiv K Gupta

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|March 17, 2017
Inhibiting DNA-PK<sub>CS</sub> radiosensitizes human osteosarcoma cellsTewodros Mamo, Ann C Mladek, Kris L Shogren, et al.
International Journal of Radiation Biology|May 22, 2014
Design and characterization of an economical (192)Ir hemi-brain small animal irradiatorMichael P Grams, Zachary C Wilson, Terence T Sio, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2017
Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of GlioblastomaJanice K Laramy, Minjee Kim, Shiv K Gupta, et al.
ACS Applied Materials & Interfaces|July 31, 2015
Fast Response and High Sensitivity of ZnO Nanowires-Cobalt Phthalocyanine Heterojunction Based H2S SensorAshwini Kumar, Soumen Samanta, Ajay Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2012
Inhibition of histone deacetylation potentiates the evolution of acquired temozolomide resistance linked to MGMT upregulation in glioblastoma xenograftsGaspar J Kitange, Ann C Mladek, Brett L Carlson, et al.
Molecular Cancer Therapeutics|March 31, 2021
<i>In Vivo</i> Efficacy of Tesevatinib in <i>EGFR</i>-Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory SignalingSani H Kizilbash, Shiv K Gupta, Karen E Parrish, et al.
Molecular Cancer Therapeutics|September 27, 2017
Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in GlioblastomaSani H Kizilbash, Shiv K Gupta, Kenneth Chang, et al.
Science Translational Medicine|February 14, 2024
Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitizationJiajia Chen, Daniel J Laverty, Surabhi Talele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in GlioblastomaJenny L Pokorny, David Calligaris, Shiv K Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2024
Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma ModelsSonia Jain, Jessica I Griffith, Kendra A Porath, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|March 17, 2017
Inhibiting DNA-PK<sub>CS</sub> radiosensitizes human osteosarcoma cellsTewodros Mamo, Ann C Mladek, Kris L Shogren, et al.
International Journal of Radiation Biology|May 22, 2014
Design and characterization of an economical (192)Ir hemi-brain small animal irradiatorMichael P Grams, Zachary C Wilson, Terence T Sio, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2017
Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of GlioblastomaJanice K Laramy, Minjee Kim, Shiv K Gupta, et al.
ACS Applied Materials & Interfaces|July 31, 2015
Fast Response and High Sensitivity of ZnO Nanowires-Cobalt Phthalocyanine Heterojunction Based H2S SensorAshwini Kumar, Soumen Samanta, Ajay Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2012
Inhibition of histone deacetylation potentiates the evolution of acquired temozolomide resistance linked to MGMT upregulation in glioblastoma xenograftsGaspar J Kitange, Ann C Mladek, Brett L Carlson, et al.
Molecular Cancer Therapeutics|March 31, 2021
<i>In Vivo</i> Efficacy of Tesevatinib in <i>EGFR</i>-Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory SignalingSani H Kizilbash, Shiv K Gupta, Karen E Parrish, et al.
Molecular Cancer Therapeutics|September 27, 2017
Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in GlioblastomaSani H Kizilbash, Shiv K Gupta, Kenneth Chang, et al.
Science Translational Medicine|February 14, 2024
Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitizationJiajia Chen, Daniel J Laverty, Surabhi Talele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in GlioblastomaJenny L Pokorny, David Calligaris, Shiv K Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2024
Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma ModelsSonia Jain, Jessica I Griffith, Kendra A Porath, et al.
Pageof 4